advanced search

Drug Delivery & Environmental Sustainability153

Issue No #153 Oct/Nov 2023  October 29th, 2023


Download PDF


Issue 153 - OctNov 2023

Inside the magazine

TRANSFORMING PHARMA MANUFACTURING TO DRIVE SUSTAINABILITY AND COST EFFICIENCY
EXPERT VIEW
Michael Astle
TRANSFORMING PHARMA MANUFACTURING TO DRIVE SUSTAINABILITY AND COST EFFICIENCY
Michael Astle, Gareth Jenkins and Edward Mayo explore current strategies to reduce carbon emissions and drive cost efficiency throughout the healthcare industry.
MAKING LOW-CARBON-EMISSION SINGLE-USE MEDICAL DEVICES A REALITY
SUSTAINABILITY
Dr Veluska Bruce
SHL Medical
MAKING LOW-CARBON-EMISSION SINGLE-USE MEDICAL DEVICES A REALITY
Veluska Bruce discusses the design and development of single-use autoinjectors in the context of sustainable development.
SUSTAINABILITY IN DRUG DELIVERY – STATE OF PLAY IN 2023
SUSTAINABILITY
Isobel Filipova
Owen Mumford
SUSTAINABILITY IN DRUG DELIVERY – STATE OF PLAY IN 2023
Isobel Filipova of Owen Mumford explains where the healthcare industry stands on current environmental objectives, identifies obstacles to achieving sustainability in drug delivery and looks at how the sector can make progress to meet its objectives.
TIPS AND TRICKS FOR IMPLEMENTING SUSTAINABILITY INITIATIVES
SUSTAINABILITY
Henryk Badack
Vetter Pharma
TIPS AND TRICKS FOR IMPLEMENTING SUSTAINABILITY INITIATIVES
Henryk Badack outlines Vetter's efforts to establish sustainable business practices.
THE EVOLUTION OF THE PHARMA ECOSYSTEM: PRODUCT PERFORMANCE NOW MEETS SUSTAINABILITY
SUSTAINABILITY
Dr Bettine Boltres
West Pharmaceutical Services
THE EVOLUTION OF THE PHARMA ECOSYSTEM: PRODUCT PERFORMANCE NOW MEETS SUSTAINABILITY
Bettine Boltres and Shivani Polasani discuss how pharma can progress towards a more sustainable future, and consider the role that the collaboration between Corning and West Pharmaceutical Services can play in supporting pharma’s sustainability goals.
DRIVING SUSTAINABLE DRUG DELIVERY DEVICES WITH CONTINUOUS IMPROVEMENT PROCESSES
SUSTAINABILITY
Marc Severin
H&T Presspart
DRIVING SUSTAINABLE DRUG DELIVERY DEVICES WITH CONTINUOUS IMPROVEMENT PROCESSES
Marc Severin discusses the H&T Excellence programme and how it has been expanded to include methods and training to help H&T Presspart identify environmental impact at a product group level and take co-ordinated action to reduce carbon emissions across the organisation.
GREEN THINKING: HOW TO BECOME A MORE SUSTAINABLE ORGANISATION
SUSTAINABILITY
André Jansen
IGS GeboJagema
GREEN THINKING: HOW TO BECOME A MORE SUSTAINABLE ORGANISATION
André Jansen and Ron Cisliek describe how high-precision mould maker IGS GeboJagema is fostering a culture of “green thinking” and making sustainability a core part of its business.
ENVIRONMENTAL DRIVERS FOR CHANGE IN DRUG DELIVERY DEVICES
EXPERT VIEW
Will Morris
ENVIRONMENTAL DRIVERS FOR CHANGE IN DRUG DELIVERY DEVICES
Will Morris discusses the positive changes that have occurred when it comes to environmental sustainability in the medical industry, in the context of examining what more can be done.
SUSTAINABILITY UNLEASHED: DRIVING POSITIVE IMPACT IN THE PHARMA INDUSTRY
SUSTAINABILITY
Justin Schroeder
PCI Pharma Services
SUSTAINABILITY UNLEASHED: DRIVING POSITIVE IMPACT IN THE PHARMA INDUSTRY
Justin Schroeder, Ann Cartwright and Gigi Bat-Erdene discuss the unique challenges facing the pharmaceutical industry in adopting environmental, social and governance principles, and present a way forward to achieve the necessary goal of improving sustainability within the industry.
SHAPING A SUSTAINABLE BIOPHARMA INDUSTRY
EXPERT VIEW
Jimin Han
SHAPING A SUSTAINABLE BIOPHARMA INDUSTRY
Jimin Han delves into the intricate landscape of sustainability challenges within the biopharma industry and explores the innovative solutions that are steering drug development toward a greener future.
HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN
EXPERT VIEW
Paramesh Natarajan
HOW LIFECYCLE ASSESSMENT SUPPORTS INSIGHT-DRIVEN SUSTAINABLE DESIGN
Paramesh Natarajan, Shadi Bavar and Charlie Dean present the case for using screening lifecycle assessments to lead into more detailed targeted and comprehensive lifecycle assessments focused on the areas of greatest environmental impact, using a screening lifecycle assessment of a hypothetical body-worn injector as an example.
Top